Skip to main content
Caplight Logo









Visano Theranostics

Visano Theranostics

Private
Fairview Park, OhioHealthcare & Life Scienceshttps://visanotheranostics.com/

Last Round

Seed

Jan 8, 2026

Total Funding Raised

$445,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Visano Theranostics is a biotechnology company developing next-generation nanobubble ultrasound contrast agents for the precise diagnosis and treatment of prostate cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

ultrasound contrast agentprostate cancer diagnosisnanobubble technologytheranosticsPSMA-targetedprostate biopsymolecular imagingtransrectal ultrasoundTRUStargeted nanobubble therapyTNTimage-guided therapycontrast-enhanced ultrasoundCEUSmedtech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Visano Theranostics Comparables

Compare Visano Theranostics with similar companies based on industry and business-model similarity.

Visano Theranostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bracco S.p.A.
63%
Apeikon Therapeutics
63%
Microvascular Therapeutics, Inc.
63%

Visano Theranostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 8, 2026
AcceleratorOct 1, 2025
GrantJul 22, 2025

Visano Theranostics Investors

Notable investors and investment history

Visano Theranostics investors
InvestorRounds
Ohio Third Frontier CommissionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    $250K raised in Seed round.

  • Oct 1, 2025

    $275K raised in Accelerator round

Visano Theranostics Filings

Explore SEC and related filing metadata, where available.

Visano Theranostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Visano Theranostics's valuation, stock price, and market status.

Is Visano Theranostics a public or private company?

Visano Theranostics is a private company.

What is the current stock price of Visano Theranostics?

Visano Theranostics is a private company with no public stock price. No recent secondary market data is available.

How much is Visano Theranostics worth (valuation)?

Valuation information for Visano Theranostics is not publicly available.

Can I buy Visano Theranostics stock?

Visano Theranostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Visano Theranostics's last funding round?

Visano Theranostics's most recent funding round was Seed on January 8, 2026.

Who are the main investors in Visano Theranostics?

Key investors in Visano Theranostics include Ohio Third Frontier Commission.

Will Visano Theranostics IPO soon?

No public IPO plans have been announced for Visano Theranostics.

How can I track Visano Theranostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Visano Theranostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFairview Park, Ohio
Year Founded2024
Last FundingJan 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?